hotspot -WSS

hotspot

author：explore 2025-10-02 00:18:28 - browse：399

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： FDA advisers back CAR

WSS

After traumatic brain injury, life support decisions can use more time

RaDonda Vaught links Vanderbilt hospital issues to patient death

EPA limits use of carcinogenic gas for sterilizing medical devices

Why scientists need input from humanists on sensitive research

Cue Health's Covid

Change Healthcare outage fallout shows need for new oversight

entertainment

hotspot

knowledge

At least 13 dead in Texas as scorching temps continue

RaDonda Vaught links Vanderbilt hospital issues to patient death

BioMarin wins approval for gene therapy to treat hemophilia A

Pushing for an NIH office for post

Alkermes shareholders re

UnitedHealth financials solid despite Change Healthcare cyberattack

Bright Health sells Medicare Advantage business to Molina

How many hemophilia patients actually want gene therapy?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Melinda French Gates resigns from Gates Foundation

entertainment

MultiPlan and major insurers sued for alleged medical price

Getting Alzheimer's drug Leqembi to patients can be a challenge

Pushing for an NIH office for post

Pushing for an NIH office for post

President Biden's budget: Here's what you might have missed

Cell therapy fails to slow type 1 diabetes, but safety is established

focus

focus

hotspot

hotspot